CUE icon

Cue Biopharma

74 hedge funds and large institutions have $185M invested in Cue Biopharma in 2020 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

10% more capital invested

Capital invested by funds: $168M → $185M (+$17.5M)

3.29% more ownership

Funds ownership: 45.91%49.2% (+3.3%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $443K

Holders
74
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
$443K
Net Calls
Net Calls Change

Top Buyers

1 +$15.6M
2 +$7.59M
3 +$5.88M
4
Goldman Sachs
Goldman Sachs
New York
+$2.22M
5
GTC
Ghost Tree Capital
New York
+$1.77M

Top Sellers

1 -$1.14M
2 -$826K
3 -$627K
4
Morgan Stanley
Morgan Stanley
New York
-$522K
5
HSBC Holdings
HSBC Holdings
United Kingdom
-$473K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$168K
52
$164K
53
$150K
54
$149K
55
$142K
56
$122K
57
$105K
58
$102K
59
$102K
60
$94K
61
$93K
62
$87.5K
63
$86K
64
$67K
65
$57K
66
$44K
67
$28K
68
$22K
69
$13K
70
$9K
71
$7K
72
$2K
73
$2K
74
$2K
75